Beutner launches autoimmune blistering disease test

By staff writers

August 3, 2022 -- KSL Beutner Laboratories (Beutner) has launched a blood test to detect an antigen linked with the autoimmune blistering disease mucous membrane pemphigoid (MMP), which often causes painful lesions in the oral cavity.

The indirect immunofluorescence serum blood test detects laminin 32, the antigen associated with MMP, which causes lesions that often scar and can be life-threatening if they are left untreated. In up to 90% of cases, lesions occur in the gums, the lining of the cheeks and lips, the palate, and the tongue.

The test, which reduces a confirmed diagnosis from two years to 72 hours or less, can assist periodontists, dentists, and other clinicians in treating patients with a disease that is often misdiagnosed.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking